#egn13
People power
The ‘people legacy’ session at the EGN Conference came at an interesting time for me personally. I’m about to be made unemployed, and to go along to a session celebrating the capacity-building function of the network – its ability to launch its graduates and postdocs on successful careers – brings mixed feelings. The rather significant unsaid at this week’s conference is that the end of a major research council investment, such as the Genomics Forum and the ESRC funding for the three EGN centres, brings at least the potential for large-scale unemployment.
I can’t speak for the other centres in the Genomics Network.
But at the Forum, although the threat of mass unemployment has receded, several
staff (myself included) still don’t know where we’ll end up next. That’s not
quite true – I know I’ve got a well-deserved and well-planned summer break
first of all. But come the autumn, I may or may not have my dream fellowship
funded elsewhere at the University of Edinburgh. And if I don’t, who knows?
Planning a career break is not something I’ve done lightly,
and I certainly wouldn’t change the decision. But there are moments when I do
question my faith in my own employability, such as when I talk to other
research fellows who’ve interviewed for the same fellowship schemes I’ve
applied for, and then been turned down. Am I just demonstrating breathtaking
levels of Gen-Y arrogance? Will I find myself locked out of academia for good,
REFability or no REFability?
At gutter-gazing moments like these, it’s always good to go to
a conference session dedicated to the stellar success of former EGN PhD
students and fellows. 89 PhD students completed during the lifespan of the EGN
– a very considerable achievement, as chair Steve Sturdy pointed out, on top of
the core research outputs of the centres. Of these, 4 spoke about their
postgraduate and postdoctoral experiences in this session.
Heather Walmsley studied at the Lancaster branch of Cesagen and
is now Banting Fellow and Postdoctoral Teaching Fellow at the University of
British Columbia. Hristina Petkova did a PhD in health economics at Egenis and
now works at King’s College London. Farah Huzair studied agricultural biotech
innovation at Innogen at the Open University, moved to Canada for a postdoc at
Dalhousie, and has now returned to Innogen at the OU. Jonathan Suk, a former Genomics
Forum Research Fellow, now works for the European Centre for Disease Prevention
and Control.
These are sparkling stories and they go some way towards
justifying my belief that I should dry-clean my interview suit and polish my
shoes, just in case. But there are also stories behind these stories that I’d
like to hear. All 4 of the speakers in the session had made significant moves –
across the pond, the North Sea, or the country. Were these upheavals wanted?
Were they planned? Are even the most successful junior academics subject to
circumstance, and the assumption that we can pack our bags and our lives at a
moment’s notice and traipse across the world to follow a job? What becomes of
friendships, relationships and family ties in these situations?
There are certainly rich personal gains to be had out of
academic adventure, and I’m not (just) talking about money and professional
success. But are there other personal costs? What is gained and what is lost
when Dr 20-Something packs up and ships out? These aren’t just gains and losses
for the individual, but for the institution that has invested time and money in
her or his training.
One of the reasons I believe the EGN has been so successful
– and we heard much about its success from Paul Boyle, Chief Executive of the
ESRC, in his closing remarks later in the day – is the employment security it
has offered to junior and senior staff alike. My own 5-year postdoctoral contract
is extremely unusual, and my peers across the network have been similarly
fortunate. This security has nurtured capacity and careers, allowing enormous
scope for creativity in research, knowledge exchange and public engagement.
At this uncertain moment, I can only express two hopes. First,
I hope that this investment pays off, for me and others in similar positions across
the network. Second, I hope the EGN’s ‘people legacy’ reminds the ESRC and
other research funders of the value of investing in early-career security and
stability.
HOW I GOT CURED OF HERPES VIRUS.
ReplyDeleteHello everyone out there, i am here to give my testimony about a herbalist called dr imoloa. i was infected with herpes simplex virus 2 in 2013, i went to many hospitals for cure but there was no solution, so i was thinking on how i can get a solution out so that my body can be okay. one day i was in the pool side browsing and thinking of where i can get a solution. i go through many website were i saw so many testimonies about dr imoloa on how he cured them. i did not believe but i decided to give him a try, i contacted him and he prepared the herpes for me which i received through DHL courier service. i took it for two weeks after then he instructed me to go for check up, after the test i was confirmed herpes negative. am so free and happy. so, if you have problem or you are infected with any disease kindly contact him on email drimolaherbalmademedicine@gmail.com. or / whatssapp --+2347081986098.
This testimony serve as an expression of my gratitude. he also have
herbal cure for, FEVER, DIARRHOEA, MOUTH ULCER, MOUTH CANCER FATIGUE, MUSCLE ACHES, LUPUS, SKIN CANCER, PENILE CANCER, BREAST CANCER, PANCREATIC CANCER, CHRONIC KIDNEY DISEASE, VAGINAL CANCER, CERVICAL CANCER, DISEASE, JOINT PAIN, POLIO DISEASE, PARKINSON'S DISEASE, ALZHEIMER'S DISEASE, INFLAMMATORY JOINT DISEASE CYSTIC FIBROSIS, SCHIZOPHRENIA, CORNEAL ULCER, EPILEPSY, FETAL ALCOHOL SPECTRUM, LICHEN PLANUS, COLD SORE, SHINGLES, CANCER, HEPATITIS A, B. DIABETES 1/2, HIV/AIDS, CHRONIC PANCERATIC, CHLAMYDIA, ZIKA VIRUS, EMPHYSEMA, LOW SPERM COUNT, ENZYMA, DRY COUGH, ARTHRITIS, LEUKAEMIA, LYME DISEASE, ASTHMA, IMPOTENCE, BARENESS/INFERTILITY, WEAK ERECTION, PENIS ENLARGEMENT. AND SO ON.